Novartis India, one of the leading pharma companies, witnessed a sharp fall in share price on Friday on reports suggesting that Novartis AG, parent company, is considering delisting of Indian unit,  Novartis India from the Bombay Stock Exchange.

However, the company has clarified that, 'We are not aware about the source of this news. The board of the company has not received any notice from the promoters of the company, Novartis AG on its intention to delist the equity shares of the company from the BSE Limited.'

Shares of Novartis India are trading at Rs 762.65, down Rs 75.95, or 9.06% at the Bombay Stock Exchange (BSE) on Friday at 11:05 a.m.

The scrip has touched an intra-day high of Rs 780 and low of Rs 725.50. The total volume of shares traded at the BSE is 344,067.